Profile: Escreen, Inc. manufactures and markets an automated, instant, clinic-based rapid drug testing device. The drug screening industry is highly fragmented and the testing process requires extensive, time-consuming paper management and extended turnaround time on test results. We are able to offer a rapid, electronic, paperless solution to collection facilities to service their customers in the most efficient and consistent method possible. Our product list comprises of paperless chain of custody (CCF) & ePad, eCup and eReader. The eCup is a self contained testing device that does not require pouring, transferring or pipetting of the specimen. It consists of a dumb cup and a smart lid. The smart lid contains reagent test strips, sensitive to the five-test substance abuse and mental health services administration (SAMHSA) profile cutoff levels. The specimen is collected in the eCup, sealed and entered into the eScreen software. The eCup is inserted into the reader and with one click of the mouse, the latter is activated & completes the screening process without any further human involvement.
The company was founded in 1998.
FDA Registration Number: 2032801
8 Products/Services (Click for related suppliers)
|
| • Cannabinoids Enzyme Immunoassay Test (FDA Code: LDJ / 862.3870) A cannabinoid test system is a device intended to measure any of the cannabinoids, hallucinogenic compounds endogenous to marihuana, in serum, plasma, saliva, and urine. Cannabinoid compounds includedelta -9-tetrahydrocannabinol, cannabidiol, cannabinol, and cannabichromene. Measurements obtained by this device are used in the diagnosis and treatment of cannabinoid use or abuse and in monitoring levels of cannabinoids during clinical investigational use. |
| • Cocaine and Cocaine Metabolites Enzyme Immunoassay Test (FDA Code: DIO / 862.3250) A cocaine and cocaine metabolite test system is a device intended to measure cocaine and a cocaine metabolite (benzoylecgonine) in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of cocaine use or overdose. |
| • Healthcare Service |
| • Medical Software Solutions |
| • Methamphetamine Gas Chromatography Test (FDA Code: LAF / 862.3610) A methamphetamine test system is a device intended to measure methamphetamine, a central nervous system stimulating drug, in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of methamphetamine use or overdose. |
| • Opiates Enzyme Immunoassay Test (FDA Code: DJG / 862.3650) An opiate test system is a device intended to measure any of the addictive narcotic pain-relieving opiate drugs in blood, serum, urine, gastric contents, and saliva. An opiate is any natural or synthetic drug that has morphine-like pharmocological actions. The opiates include drugs such as morphine, morphine glucoronide, heroin, codeine, nalorphine, and meperedine. Measurements obtained by this device are used in the diagnosis and treatment of opiate use or overdose and in monitoring the levels of opiate administration to ensure appropriate therapy. |
| • Phencyclidine Enzyme Immunoassay (FDA Code: LCM) |
| • Testing Devices |